Phase I trial of FRM-0334 in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 10 Feb 2015
At a glance
- Drugs FRM 0334 (Primary)
- Indications Alzheimer's disease; Dementia; Neurodegenerative disorders
- Focus Adverse reactions
- 10 Feb 2015 Results were published in a FORUM Pharmaceuticals media release.
- 15 Dec 2009 New trial record.